Krystal Biotech, Inc. (KRYS)
309.83
+8.07
(+2.67%)
USD |
NASDAQ |
Jun 09, 16:00
309.83
0.00 (0.00%)
After-Hours: 16:12
Krystal Biotech SG&A Expense (Quarterly) : 41.01M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 1.230M |
| TG Therapeutics, Inc. | 88.22M |
| Vericel Corp. | 49.23M |
| Catalyst Pharmaceuticals, Inc. | 43.52M |
| Exelixis, Inc. | 139.60M |